Bristol-Myers Squibb
BMY
#186
Rank
NZ$197.89 B
Marketcap
NZ$97.21
Share price
5.28%
Change (1 day)
0.08%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.17. In 2024 the company made an earnings per share (EPS) of NZ-$7.69 a decrease over its 2023 EPS that were of NZ$6.75.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-166.55%
2024NZ-$7.69-213.92%
2023NZ$6.7530.2%
2022NZ$5.19-6.04%
2021NZ$5.52-179.29%
2020NZ-$6.96-281.37%
2019NZ$3.84-27.21%
2018NZ$5.27
2016NZ$4.65175.26%
2015NZ$1.69-19.83%
2014NZ$2.11-22.44%
2013NZ$2.7134.48%
2012NZ$2.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.99-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.21 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.71 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.81 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$6.45 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$5.28 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$18.17 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.35-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.67 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.12 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA